Research Article

Thrombopoietin Receptor Agonist Mitigates Hematopoietic Radiation Syndrome and Improves Survival after Whole-Body Ionizing Irradiation Followed by Wound Trauma

Figure 6

RI and CI decreased survival and Alxn4100TPO improved survival after CI. Animals were monitored for 30 days. = 19–22 per group. For panel (a): versus sham and W; versus RI. For panel (c): versus CI + Vehicle. For panel (d): versus sham and W; versus RI + Vehicle; versus CI + vehicle. W: wound; RI: 9.5 Gy; CI: 9.5 Gy and skin wound.
(a) Vehicle mice
(b) RI mice
(c) CI mice
(d) Vehicle versus Alxn4100TPO